Clinical Trial

Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate the characteristics of the microbiota-gut-brain axis in pediatric patients with obsessive-compulsive disorder (OCD) through performing an integrated analysis of gut microbiota, serum metabolomics, neuroimaging and electroencephalography (EEG), conducted before and after treatment with selective serotonin reuptake inhibitors (SSRIs). The results will be compared with those of pediatric OCD paitents comorbid with tic disorder (TD) and healthy controls. The findings are expected to further elucidate the potential pathogenesis of OCD, providing a theoretical basis for identifying novel clinical intervention targets and optimizing treatment strategies.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Recruiting 2026-08-04
Trial Details
NCT Number NCT06754319
Lead Sponsor Shanghai Mental Health Center
Conditions Obsessive-Compulsive Disorder, Tic Disorder
Enrollment 125 participants
Start Date 2024-08-24
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03